A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Therapeutic potential of thymosin beta 4 in myocardial infarct and heart failure
Tekijät: Stark C, Taimen P, Tarkia M, Parkka J, Saraste A, Alastalo TP, Savunen T, Koskenvuo J
Julkaisuvuosi: 2012
Journal: Annals of the New York Academy of Sciences
Tietokannassa oleva lehden nimi: THYMOSINS IN HEALTH AND DISEASE I
Lehden akronyymi: ANN NY ACAD SCI
Vuosikerta: 1269
Aloitussivu: 117
Lopetussivu: 124
Sivujen määrä: 8
ISSN: 0077-8923
DOI: https://doi.org/10.1111/j.1749-6632.2012.06695.x
Tiivistelmä
Thymosin beta 4 (T beta 4) is a peptide known for its abilities to protect and facilitate regeneration in a number of tissues following injury. Its cardioprotective effects have been evaluated in different animal models and, currently, a clinical trial is being planned in patients suffering from acutemyocardial infarction. This paper focuses on the effects of T beta 4 on cardiac function in animal studies utilizing different imaging modalities for outcome measurements.
Thymosin beta 4 (T beta 4) is a peptide known for its abilities to protect and facilitate regeneration in a number of tissues following injury. Its cardioprotective effects have been evaluated in different animal models and, currently, a clinical trial is being planned in patients suffering from acutemyocardial infarction. This paper focuses on the effects of T beta 4 on cardiac function in animal studies utilizing different imaging modalities for outcome measurements.
Turun yliopiston Tutkimustietojärjestelmän portaali